Comparing intensive vs. standard blood pressure control for primary aldosteronism
Part of Hormones & metabolism clinical trials.
This trial tests whether a more intensive approach to lowering blood pressure is better than standard treatment for people with primary aldosteronism (a condition where the adrenal glands make too much aldosterone, leading to high blood pressure). It aims to find which strategy reduces the risk of heart problems more effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have primary aldosteronism, confirmed by specific blood tests.
- Your systolic blood pressure (the top number) is between 140 and 190 mmHg, or you are already on blood pressure medication.
- You have at least one sign of increased heart or blood vessel risk, such as a past heart attack, stroke, or certain risk factors like diabetes or smoking.
- You are not planning to have surgery for your adrenal condition.
- You have not had a heart attack, stroke, or heart procedure in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies people with high blood pressure caused by a hormone problem called primary aldosteronism. If you qualify, the study may help doctors learn better ways to identify and manage this specific cause of blood pressure elevation.
This trial looks at whether adding spironolactone to your current blood pressure medicines works better for people with primary aldosteronism (a condition where your adrenal glands make too much aldosterone, raising blood pressure). You may qualify if you have this form of high blood pressure but have declined surgery or don't have an adenoma.
This trial compares different ways of doing adrenal vein sampling (a test to find which adrenal gland is causing high blood pressure). It aims to see if combining methods works better than using just one for people with primary aldosteronism.
This trial tests whether a simple steroid-based test can help identify a specific type of high blood pressure called primary aldosteronism. If you have high blood pressure that needs medication, this study may help find a treatable cause.
This trial looks for better ways to diagnose primary aldosteronism (PA), a common cause of high blood pressure that can be treated. It may help find people whose hypertension is caused by this condition so they can get the right treatment sooner.
This study tests whether adjusting a type of blood pressure medication (called a mineralocorticoid receptor antagonist) based on renin levels is safe and helpful for people with primary aldosteronism. It aims to find a better way to manage the condition.
Hear when a new Primary Aldosteronism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.